Literature DB >> 21667435

Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress.

D Macut1, T Simic, A Lissounov, M Pljesa-Ercegovac, I Bozic, T Djukic, J Bjekic-Macut, M Matic, M Petakov, S Suvakov, S Damjanovic, A Savic-Radojevic.   

Abstract

To get more insight into molecular mechanisms underlying oxidative stress and its link with insulin resistance, oxidative stress parameters, as well as, antioxidant enzyme activities were studied in young, non-obese women with polycystic ovary syndrome (PCOS). Study was performed in 34 PCOS women and 23 age and body mass index (BMI)-matched healthy controls. Plasma nitrotyrosine and malondialdehyde (MDA), representative byproducts of protein and lipid oxidative damage, were determined by enzyme immunoassay. Antioxidant enzyme activities, superoxide dismutase (SOD) and glutathione peroxidase (GPX) were studied spectrophotometrically. Insulin resistance was calculated using homeostasis assessment model (HOMA-IR). Plasma nitrotyrosine and MDA were increased, but only nitrotyrosine was significantly higher (p < 0.05) in PCOS women compared to controls. Uric acid (surrogate marker of × antine oxidase) was also significantly elevated in PCOS (p < 0.05). Both plasma SOD and GPX activity showed no statistically significant difference between PCOS and controls. Indices of insulin resistance (insulin and HOMAIR) were significantly higher in PCOS group and positively correlated with level of MDA (r = 0.397 and r = 0.523, respectively; p < 0.05) as well as GPX activity (r = 0.531 and r = 0.358, respectively; p < 0.05). Our results indicate that insulin resistance could be responsible for the existence of subtle form of oxidative stress in young, nonobese PCOS women. Hence, presence of insulin resistance, hyperinsulinemia and oxidative damage are likely to accelerate slow development of cardiovascular disease in PCOS. © J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21667435     DOI: 10.1055/s-0031-1279740

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  13 in total

1.  Defining the role of bariatric surgery in polycystic ovarian syndrome patients.

Authors:  Shaveta M Malik; Michael L Traub
Journal:  World J Diabetes       Date:  2012-04-15

Review 2.  Cardiovascular risk factors and events in women with androgen excess.

Authors:  D Macut; I B Antić; J Bjekić-Macut
Journal:  J Endocrinol Invest       Date:  2014-11-29       Impact factor: 4.256

3.  Cardiac fatty acid uptake and metabolism in the rat model of polycystic ovary syndrome.

Authors:  Snežana Tepavčević; Danijela Vojnović Milutinović; Djuro Macut; Mojca Stojiljković; Marina Nikolić; Ivana Božić-Antić; Tijana Ćulafić; Jelica Bjekić-Macut; Gordana Matić; Goran Korićanac
Journal:  Endocrine       Date:  2015-02-22       Impact factor: 3.633

4.  Effects of propylene glycol or elevated luteinizing hormone during follicle development on ovulation, fertilization, and early embryo development.

Authors:  Katherine S Hackbart; Robb W Bender; Paulo D Carvalho; Lais M Vieira; Ana R Dresch; Jerry N Guenther; Hidir Gencoglu; Anibal B Nascimento; Randy D Shaver; Milo C Wiltbank
Journal:  Biol Reprod       Date:  2017-10-01       Impact factor: 4.285

Review 5.  Association of Superoxide Dismutase Level in Women with Polycystic Ovary Syndrome.

Authors:  Arshi Talat; P Satyanarayana; Pallavi Anand
Journal:  J Obstet Gynaecol India       Date:  2021-07-06

6.  Serum uric acid in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study.

Authors:  Sunni L Mumford; Sonya S Dasharathy; Anna Z Pollack; Neil J Perkins; Donald R Mattison; Stephen R Cole; Jean Wactawski-Wende; Enrique F Schisterman
Journal:  Hum Reprod       Date:  2013-04-05       Impact factor: 6.918

7.  Finding novel molecular connections between developmental processes and disease.

Authors:  Jisoo Park; Heather C Wick; Daniel E Kee; Keith Noto; Jill L Maron; Donna K Slonim
Journal:  PLoS Comput Biol       Date:  2014-05-29       Impact factor: 4.475

8.  Evaluation of a Summary Score for Dyslipidemia, Oxidative Stress and Inflammation (the Doi Score) in Women with Polycystic Ovary Syndrome and its Relationship with Obesity.

Authors:  Iva Perović Blagojević; Svetlana Ignjatović; Djuro Macut; Jelena Kotur-Stevuljević; Ivana Božić-Antić; Jelena Vekić; Jelica Bjekić-Macut; Biljana Kastratović-Kotlica; Zoran Andrić; Dušan Ilić
Journal:  J Med Biochem       Date:  2018-12-01       Impact factor: 3.402

Review 9.  Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk.

Authors:  Srdan Pandurevic; Djuro Macut; Flaminia Fanelli; Uberto Pagotto; Alessandra Gambineri
Journal:  Biomolecules       Date:  2021-09-12

Review 10.  Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers.

Authors:  Tao Zuo; Minghui Zhu; Wenming Xu
Journal:  Oxid Med Cell Longev       Date:  2015-12-06       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.